European Commission Issues Decision on Taliglucerase Alfa Marketing Authorization Application

European Commission Issues Decision on Taliglucerase Alfa Marketing Authorization Application

[at noodls] – NEW YORK and CARMIEL, Israel, Nov. 1, 2012 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX, TASE:PLX) today announced that the European Commission (EC) has issued … more

View todays social media effects on PLX

View the latest stocks trending across Twitter. Click to view dashboard

Share this post